Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pharmacokinetics in Oral and Intranasal Formulations of Zolmitriptan.
Sponsor: Parc de Salut Mar
Summary
This is a phase I study to evaluate the PBPK of zolmitriptan intranasal versus oral administration.
Official title: Pharmacokinetic Model Based on Population Physiology of Oral and Intranasal Formulations of Zolmitriptan in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2023-07-12
Completion Date
2023-09-29
Last Updated
2026-05-05
Healthy Volunteers
Yes
Conditions
Interventions
Zolmitriptan intranasal.
Zolmitriptan nasal spray is supplied in a single-use, ready-to-use spray unit. It is administered in one nostril. The full protocol will explain how to use it. Following drug administration, study subjects will continue to fast for a minimum of 4h and snacks and standard meals may be served at scheduled times after drug administration (snack: +4h; lunch: +7h; snack: +10h). Liquid intake will not be allowed from 2h before to 2h after drug administration.
Zolmitriptan oral.
Zolmitriptan 5 mg orally disintegrating tablet is to be taken without liquids. For oral administration, each tablet will be placed in the top of the tongue without any liquid and will disperse in a matter of seconds, then be swallowed with saliva. Following drug administration, study subjects will continue to fast for a minimum of 4h and snacks and standard meals may be served at scheduled times after drug administration (snack: +4h; lunch: +7h; snack: +10h). Liquid intake will not be allowed from 2h before to 2h after drug administration.
Locations (1)
IMIM (Hospital del Mar Medical Research Institute)
Barcelona, Spain